ERBB2 and urinary bladder cancer: It has been reported that in bladder cancer cells, combined treatment with curcumin and low doses of standard clinical drugs, including cisplatin, reversed drug resistance, inhibited cell proliferation and induced apoptosis by suppressing the expression of HER2, an oncogenic protein involved in bladder cancer [76].